Skip to content

Feasibility of the UriCap-F for Urine Collection in Hospitalized Women

Feasibility of the UriCap-F for Urine Collection in Hospitalized Women

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02530372
Enrollment
30
Registered
2015-08-21
Start date
2015-09-30
Completion date
2015-11-30
Last updated
2015-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Incontinence

Brief summary

The study will evaluate safety and effectiveness of the UriCap-F, a non-invasive urine collection device for women, in hospitalized patients who would otherwise be treated with an indwelling catheter, pads or diapers.

Detailed description

Following various disease conditions such as trauma, orthopaedic surgery, and infections etc., patients may be bedridden and unable to void in a bedpan or to make their way to the toilet. For lack of a better solution for urinary management, indwelling catheter and diaper use is common in hospitalized patients. There is no externally applied urine collection device on the market today for women. In such situations an indwelling catheter is often placed to relieve patients while they are incapacitated, despite lack of urinary retention. Indwelling catheters, although effective, are associated with discomfort, pain, and urinary tract infections. In other cases diapers or absorbent pads may be used. These may be associated with skin irritation and infection. The study will evaluate the UriCap-F, non-invasive urine collection devices for women, in hospitalized patients who are able to void or who are incontinent of urine

Interventions

DEVICEUriCap-F

non-invasive urine collection device for women

Sponsors

G.R. Dome Medical Ltd.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Female ≥ 18 years old * Empties the bladder completely on voiding * A clinical indication for an indwelling catheter, use of pads or diapers * Patient has signed an informed consent form, is cooperative and willing to complete all study procedures * Absence of localized disease at the site of device application - vaginal discharge, itching, inflammation or skin condition * Agrees to genital hair removal.

Exclusion criteria

* Pregnant or breastfeeding * Menstruation at time of enrolment * Known allergy to silicon * Dysuria * Urinary retention - Post-void residual urine more than 300cc * Hematuria or pyuria (turbidity) on visual inspection, according to investigator judgement. * Diagnosed with acute renal failure according, to investigator judgement. * Serious or unstable psychological condition (e.g., eating disorders, clinical depression, anxiety, emotionally labile) which, in the opinion of the Investigator, would compromise the patient's well-being or successful participation in the study * Participating in another clinical study. * Financial interest in the Sponsor Company or a competitor company by patient or a family member

Design outcomes

Primary

MeasureTime frameDescription
Patient Comfort1-30 daysComfort will be assessed by means of the Universal Pain Assessment Scale of 1-10, At every device application, every removal, and when patient complains of discomfort or pain.
Patient satisfaction in device use1-30 daysOverall treatment satisfaction will be assessed by means of a Treatment Satisfaction Questionnaire administered at termination of device use.
Healthcare provider (HCP) satisfactionup to 60 daysTreatment satisfaction will be assessed by means of a Treatment Satisfaction Questionnaire administered after termination of all study patients
Number of Adverse Device Events1-30 days
Use Safety as demonstrated by System Usability Score assessed by healthcare providers1 week
Effectiveness of the device to collect urine1-30 daysMultiple variables will be assessed and their measurements aggregated to arrive at a number of events reported: * Leakage * Pooling of urine in the tubing * Tubing disconnections * Adhesive tape disconnections * Need for repositioning of device * Device malfunctions

Secondary

MeasureTime frameDescription
Leakage as a result of device movement1-30 daysTo evaluate the correlation between leakage and device repositioning data
Effectiveness of defined device cleaning procedure for reuse1-30 daysThe reusable part will be visually inspected after cleaning for suitability for reuse. Devices which exhibit any of the following properties will be discarded: color change, residual soiling, loss of mechanical integrity, torn or rough edges. Effectiveness of the cleaning procedure will be measured as the average number of days the device can be reused.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026